Depression is common in Parkinson's disease (PD) and is associated with several poor
outcomes. However the literature regarding treatment with antidepressants in this population …

Objective To determine the frequency of depression in Parkinson's disease (PD) in routine
clinical care, and to examine its association with co‐morbid psychiatric and medical …

Background/aim: Comorbidity of depression in Parkinson disease (PD) is a major factor that
changes patients? quality of life. However, the neurobiological and sociodemographic risk …

Depression is one of the most common non-motor symptoms of Parkinson's disease (PD)
with a large negative impact on the quality of life. Factors such as disease stage, subtype of …

Background Antidepressants are one of the most prescribed classes of medications. A
number of case reports have linked these drugs to extrapyramidal symptoms (EPSs), but no …

Objective: To evaluate whether depression in Parkinson disease (PD) is more closely
related to the underlying neuropathological process or to environmental and psychological …

Although case histories of depression preceding Parkinson's disease (PD) point to a
possible pathophysiological relationship between these two disorders, there is as yet no …

This article reviews the prevalence, phenomenology, main clinical correlates, potential
mechanisms, and treatment modalities of depression in Parkinson's disease (PD). In cross …

Depression in Parkinson's disease (PD) is common, but little is known about its recognition
and treatment. The authors report the antidepressant experience (N= 100) and outcome of …

The objective of this study was to determine effect sizes for both antidepressant treatment
and placebo for depression in Parkinson's disease (PD), and to compare the findings with …